Genetic Technologies Ltd Capital Reinvestment Ratio

Latest as of March 2022: 0.24x

Genetic Technologies Ltd capital reinvestment ratio. Genetic Technologies Ltd (GTG) has a Capital Reinvestment Ratio of 0.24x as of March 2022, meaning it reinvests 0% of its operating cash flow (AU$337.45K) in capital expenditures (AU$79.79K). Check GTG cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

AU$337.45K
AUD

Capital Expenditures

AU$79.79K
AUD

Data as of

Mar 2022
Most recent filing

Capital Reinvestment Ratio of Genetic Technologies Ltd (2007–2011)

Capital reinvestment ratio of Genetic Technologies Ltd from 2007 to 2011. This chart tracks Genetic Technologies Ltd's Capital Reinvestment Ratio across 3 annual periods. Also explore Genetic Technologies Ltd (GTG) net asset momentum to track the company's year-over-year net asset growth rate.

Genetic Technologies Ltd Capital Reinvestment Ratio by Year (2007–2011)

Genetic Technologies Ltd capital reinvestment ratio by year from 2007 to 2011. For the full cash flow conversion analysis, see GTG operating cash flow.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2011 0.06x AU$2.23 Million AU$139.68K ▼ -77.6%
2008 0.28x AU$423.68K AU$118.26K ▲ +286.6%
2007 0.07x AU$2.20 Million AU$158.87K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow